Elixinol Wellness Ltd
Elixinol Wellness Limited is a global health and wellness company.
The business
Elixinol Wellness Limited is a global health and wellness company. The Company is engaged in marketing and selling hemp and other plant-derived food, skincare, and nutraceutical products. In Australia, it operates a vertically integrated business, which produces, manufactures, and distributes a range of quality products delivered across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. These products are sold under brands, including Hemp Foods Australia, The Healthy Chef, Mt Elephant, Soul Seed, Field Day, and The Australian Superfood Co, through grocery, wholesale, and e-commerce channels. In the Americas, it is engaged in marketing and selling quality Elixinol branded hemp and other plant-derived nutraceutical and skincare products. In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp and other plant-derived products are available to consumers via exclusive distribution and/or trademark and know-how licensing agreements.
Small Caps Research
No research on Elixinol Wellness Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise EXL based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Elixinol Wellness Expands Product Offering with Vitable Acquisition
Elixinol to acquire Vitable via all-scrip deal, adding subscription revenue and personalised tech; targets $27m revenue and $3m EBITDA by 2028; stock in focus.
Elixinol Global strikes exclusive multimillion-dollar deal with Pet Releaf
Cannabis company Elixinol Global (ASX: EXL) has unveiled a new manufacturing and supply agreement with Altmed Pets, otherwise known as Pet Releaf, in a deal that has the potential to add significant value to its balance sheet in the near term. The deal is worth US$18 million (A$26.8 million) over the next 18 months with a […]
Elixinol Global marks first cannabidiol shipment to New Zealand following law change
Elixinol Global’s (ASX: EXL) cannabidiol (CBD) products have now been made available on a prescription basis in New Zealand following a recent softening in legislation on medical cannabis. With prescriptions already flowing in via its e-commerce website, the company has also declared its maiden CBD shipment to the country. It comes after the passage of […]
Elixinol Global doubles in size since ASX debut, reports maiden profit
Cannabis stock Elixinol Global (ASX: EXL) has more than doubled its revenue and delivered a maiden profit in the first six months since listing on the Australian Securities Exchange. The company, which operates in the industrial hemp, dietary supplements and emerging medicinal cannabis sectors, today released its financial results for the first half of 2018, […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.